Skip to main content
Clinical Trials/ISRCTN11812525
ISRCTN11812525
Completed
Phase 2

A phase II study of preoperative chemoradiation with UFT-E plus leucovorin and the translational research for detection of predictive markers in the patients with locally advanced resectable rectal cancer

ational Cancer Center0 sites121 target enrollmentJuly 25, 2016

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
ocally advanced rectal cancer (cT3-4, Nx, M0)
Sponsor
ational Cancer Center
Enrollment
121
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 25, 2016
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ational Cancer Center

Eligibility Criteria

Inclusion Criteria

  • 1\. Histologically diagnosed adenocarcinoma of rectum
  • 2\. Located within 8cm from anal verge
  • 3\. cT3/4 by rectal MRI\+/\- endorectal ultrasound
  • 4\. 18 years old or more
  • 5\. ECOG performance status \<\=2
  • 6\. No previous chemotherapy
  • 7\. No previous radiotherapy to pelvis
  • 8\. Adequate bone marrow, hepatic, and renal function

Exclusion Criteria

  • 1\. Rectal cancer of histology other than adenocarcinoma
  • 2\. Adenocarcinoma developed from inflammatory bowel disease
  • 3\. Presence of distant metastases
  • 4\. Existence of unresected synchronous colon cancer
  • 5\. Unresolved bowel obstruction
  • 6\. Clinically unresectable disease
  • 7\. Uncontrolled cardiovascular disease
  • 8\. Uncontrolled active infection
  • 9\. History of other malignancies within 5 years from screening
  • 10\. History of organ transplantation that necessitates immunosuppressive treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials